Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001123292-26-000465
Filing Date
2026-03-17
Accepted
2026-03-17 16:29:13
Documents
1
Period of Report
2026-03-10

Document Format Files

Seq Description Document Type Size
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.html 4  
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.xml 4 7094
  Complete submission text file 0001123292-26-000465.txt   8719
Mailing Address 15 INDEPENDENCE BOULEVARD, SUITE #210 WARREN NJ 07059
Business Address 15 INDEPENDENCE BOULEVARD, SUITE #210 WARREN NJ 07059 646-807-8832
Tevogen Bio Holdings Inc. (Issuer) CIK: 0001860871 (see all company filings)

EIN.: 981597194 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O TEVOGEN BIO HOLDINGS INC. 15 INDEPENDENCE BOULEVARD WARREN NJ 07059
Business Address
Flomenberg Neal (Reporting) CIK: 0002011757 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41002 | Film No.: 26762394